]>
IRCT20230213057405N1 IRCT 2023-03-14 Ahvaz University of Medical Sciences The efficacy of serratus anterior plane block with different dose of dexmedetomidine The efficacy of serratus anterior plane block with different dose of dexmedetomidine for patients with tube thoracostomy 2023-04-21 anticipated 50 Complete https://irct.ir/trial/68644 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The patients will divide into two groups with simple randomization. in order to randomization, two groups of closed envelope will be given to them. one group is D1 and another one is D2. number of two groups is equal.the patient picks up an envelope randomly and enters at his/her group. anesthesiology resident will prepare drugs and trial will be operated double blinded, Blinding description: in this trial, anesthesiology resident will prepare the drug and anesthesiologist doctor(fellowship of pain) will insert the drug. medial intern fill the questionnaire. the patients, anesthesiology resident, anesthesiologist doctor and medial intern will not know which drug is given to which patient. so, the trial will be double_blinded. 2-3 pain in patients with tube thoracostomy. Intervention 1: Intervention group: group one that get 0.5 microgram per kg dexmedetomidine. Intervention 2: Intervention group: group two that get 1 microgram per kg dexmedetomidine. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is Because the study is under review, there is no plan for its publication
public Kamran Mahmoodi
Farvardin Street, Golestan
ahvaz Iran (Islamic Republic of) 15794 - 61357 +98 61 3311 0000 mahmoudi-k@ajums.ac.ir Ahvaz University of Medical Sciences scientific Kamran Mahmoodi
Farvardin Street, Golestan
ahvaz Iran (Islamic Republic of) 15794 - 61357 +98 61 3311 0000 mahmoudi-k@ajums.ac.ir Ahvaz University of Medical Sciences Iran (Islamic Republic of) Iran (Islamic Republic of) Patient consent to enter the study physical condition class I-II according to the standards of the Association of Anesthesiologists body mass index (BMI) less than 40 kg/m2 no pregnancy or breastfeeding no history of coagulopathy or the use of anticoagulants Ejection fraction higher than 30%, no history of conductive heart block (except for first degree heart block and controlled atrial fibrillation) the patient's level of consciousness should be above 14 no acute or chronic hepatitis no history of psychiatric disease no need for complementary Renal treatment or history of kidney failure and no neuropathy no history of drug or alcohol abuse 18 years 60 years Both Allergy to the studied drugs unwillingness of patients to cooperate Treatment - Drugs Treatment - Drugs Intervention group: group one that get 0.5 microgram per kg dexmedetomidine Intervention group: group two that get 1 microgram per kg dexmedetomidine Study groups, pain score, heart rate, systolic blood pressure, diastolic blood pressure, amount of narcotic drug use, oxygen saturation, duration of walking, duration of stay in ICU. Timepoint: nominal, distance, relative, ratio (in mm Hg), ratio (in mm Hg), ratio (in mg/k), ratio (in percentage), ratio (in minutes), ratio (in minutes). Method of measurement: According to the dose of dexmedetomidine, they are divided into two groups, 0.5 and 1. Based on the criteria, VNS describes the pain between numbers and 10, the number of heartbeats in one minute, systolic blood pressure measured by a sphygmomanometer, diastolic blood pressure measured by a sphygmomanometer, the amount of drug use. Narcotics to control the patient's pain, oxygen saturation percentage using pulse oximeter, time (using clock measurement), time (using clock measurement). Ahvaz University of Medical Sciences Approved 2022-12-13 Ethics Committee in Golestan Hospital Research Farvardin Street, Golestan ahvaz Khouzestan Iran (Islamic Republic of)